Publications
19 found
Show per page
Fernández, Lucia González, Firima, Emmanuel, Gupta, Ravi, Sematle, Mamoronts’ane Pauline, Khomolishoele, Makhebe, Molulela, Manthabiseng, Bane, Matumaole, Tlahali, Mosa, McCrosky, Stephen, Lee, Tristan, Chammartin, Frédérique, PLOS Global Public Health, 4(9). https://doi.org/10.1371/journal.pgph.0003721
, Gerber, Felix, Lejone, Thabo Ishmael, Ayakaka, Irene, Labhardt, Niklaus Daniel, & Amstutz, Alain. (2024). Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho.
Fernández, Lucia González, Firima, Emmanuel, Gupta, Ravi, Sematle, Mamoronts’ane Pauline, Khomolishoele, Makhebe, Molulela, Manthabiseng, Bane, Matumaole, Tlahali, Mosa, McCrosky, Stephen, Lee, Tristan, Chammartin, Frédérique, PLOS Global Public Health, 4(9). https://doi.org/10.1371/journal.pgph.0003721
, Gerber, Felix, Lejone, Thabo Ishmael, Ayakaka, Irene, Labhardt, Niklaus Daniel, & Amstutz, Alain. (2024). Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho.
Fernández, Lucia González, Firima, Emmanuel, Gupta, Ravi, Sematle, Mamoronts’ane, Khomolishoele, Makhebe, Molulela, Manthabiseng, Bane, Matumaole, Tlahali, Mosa, McCrosky, Stephen, Lee, Tristan, Chammartin, Frédérique, Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-3189573/v1
, Gerber, Felix, Lejone, Thabo Ishmael, Ayakaka, Irene, Labhardt, Niklaus Daniel, & Amstutz, Alain. (2023).
Fernández, Lucia González, Firima, Emmanuel, Gupta, Ravi, Sematle, Mamoronts’ane, Khomolishoele, Makhebe, Molulela, Manthabiseng, Bane, Matumaole, Tlahali, Mosa, McCrosky, Stephen, Lee, Tristan, Chammartin, Frédérique, Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-3189573/v1
, Gerber, Felix, Lejone, Thabo Ishmael, Ayakaka, Irene, Labhardt, Niklaus Daniel, & Amstutz, Alain. (2023).
Arroyo Tardio P, Baldini G, & Endocrine Connections, 12(7). https://doi.org/10.1530/EC-23-0126
. (2023). Food-induced cortisol secretion is comparable in lean and obese male subjects.
Arroyo Tardio P, Baldini G, & Endocrine Connections, 12(7). https://doi.org/10.1530/EC-23-0126
. (2023). Food-induced cortisol secretion is comparable in lean and obese male subjects.
Garweg, Justus G., Blum, Claudine A., Copt, René-Pierre, Eandi, Chiara M., Hatz, Katja, Prünte, Christian F., Ophthalmology and Therapy, 12, 639–655. https://doi.org/10.1007/s40123-023-00647-7
, & Somfai, Gábor M. (2023). Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects.
Garweg, Justus G., Blum, Claudine A., Copt, René-Pierre, Eandi, Chiara M., Hatz, Katja, Prünte, Christian F., Ophthalmology and Therapy, 12, 639–655. https://doi.org/10.1007/s40123-023-00647-7
, & Somfai, Gábor M. (2023). Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects.
Clinical Endocrinology, 96(2), 270–275. https://doi.org/10.1111/cen.14615
, Henning E, Keogh JM, Gillett D, Shin E, Buscombe J, van der Klaauw AA, & Farooqi IS. (2022). Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with delayed gastric emptying.
Clinical Endocrinology, 96(2), 270–275. https://doi.org/10.1111/cen.14615
, Henning E, Keogh JM, Gillett D, Shin E, Buscombe J, van der Klaauw AA, & Farooqi IS. (2022). Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with delayed gastric emptying.
Hohberg, Vivien, Kreppke, Jan-Niklas, Kohl, Jan, BMJ Open, 12. https://doi.org/10.1136/bmjopen-2021-057948
, Zahner, Lukas, Streckmann, Fiona, Gerber, Markus, König, Daniel, & Faude, Oliver. (2022). Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial.
Hohberg, Vivien, Kreppke, Jan-Niklas, Kohl, Jan, BMJ Open, 12. https://doi.org/10.1136/bmjopen-2021-057948
, Zahner, Lukas, Streckmann, Fiona, Gerber, Markus, König, Daniel, & Faude, Oliver. (2022). Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial.
Wueest S., Metabolites, 11(2), 1–7. https://doi.org/10.3390/metabo11020079
, Timper K, Lyngbaek M.P., Karstoft K., Donath M.Y., Ellingsgaard H., & Konrad D. (2021). Il-6 receptor blockade increases circulating adiponectin levels in people with obesity: An explanatory analysis.
Wueest S., Metabolites, 11(2), 1–7. https://doi.org/10.3390/metabo11020079
, Timper K, Lyngbaek M.P., Karstoft K., Donath M.Y., Ellingsgaard H., & Konrad D. (2021). Il-6 receptor blockade increases circulating adiponectin levels in people with obesity: An explanatory analysis.
Ellingsgaard H, Diabetologia, 63(2), 362–373. https://doi.org/10.1007/s00125-019-05045-y
, Timper K, Coslovsky M., Soederlund L, Lyngbaek MP, Wewer Albrechtsen NJ, Schmidt-Trucksäss A, Hanssen H, Frey WO, Karstoft K, Pedersen BK, Böni-Schnetzler M, & Donath MY. (2020). GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study.
Ellingsgaard H, Diabetologia, 63(2), 362–373. https://doi.org/10.1007/s00125-019-05045-y
, Timper K, Coslovsky M., Soederlund L, Lyngbaek MP, Wewer Albrechtsen NJ, Schmidt-Trucksäss A, Hanssen H, Frey WO, Karstoft K, Pedersen BK, Böni-Schnetzler M, & Donath MY. (2020). GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study.
Popovic, Milica, Timper, Katharina, PloS One, 14(5), e0217800. https://doi.org/10.1371/journal.pone.0217800
, Nordmann, Thierry, Erlanger, Tobias E., Donath, Marc Y., & Christ-Crain, Mirjam. (2019). Exercise upregulates copeptin levels which is not regulated by interleukin-1.
Popovic, Milica, Timper, Katharina, PloS One, 14(5), e0217800. https://doi.org/10.1371/journal.pone.0217800
, Nordmann, Thierry, Erlanger, Tobias E., Donath, Marc Y., & Christ-Crain, Mirjam. (2019). Exercise upregulates copeptin levels which is not regulated by interleukin-1.
Endocrinology, Diabetes & Metabolism, 2(3), e00075. https://doi.org/10.1002/edm2.75
, Trinh, Beckey, Hanssen, Henner, Schmid-Trucksäss, Arno, Ellingsgaard, Helga, Christ-Crain, Mirjam, & Donath, Marc Y. (2019). Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.
Endocrinology, Diabetes & Metabolism, 2(3), e00075. https://doi.org/10.1002/edm2.75
, Trinh, Beckey, Hanssen, Henner, Schmid-Trucksäss, Arno, Ellingsgaard, Helga, Christ-Crain, Mirjam, & Donath, Marc Y. (2019). Exercise and the dipeptidyl-peptidase IV inhibitor sitagliptin do not improve beta-cell function and glucose homeostasis in long-lasting type 1 diabetes-A randomised open-label study.
Trinh, Beckey, Hepprich, Matthias, Betz, Matthias J., Burkard, Thilo, Cavelti-Weder, Claudia, The Journal of Clinical Endocrinology and Metabolism, 104(10), 4703–4714. https://doi.org/10.1210/jc.2019-00563
, Meienberg, Fabian, Kratschmar, Denise V., Beuschlein, Felix, Reincke, Martin, Odermatt, Alex, Hall, Michael N., Donath, Marc Y., & Swierczynska, Marta M. (2019). Treatment of Primary Aldosteronism with mTORC1 Inhibitors.
Trinh, Beckey, Hepprich, Matthias, Betz, Matthias J., Burkard, Thilo, Cavelti-Weder, Claudia, The Journal of Clinical Endocrinology and Metabolism, 104(10), 4703–4714. https://doi.org/10.1210/jc.2019-00563
, Meienberg, Fabian, Kratschmar, Denise V., Beuschlein, Felix, Reincke, Martin, Odermatt, Alex, Hall, Michael N., Donath, Marc Y., & Swierczynska, Marta M. (2019). Treatment of Primary Aldosteronism with mTORC1 Inhibitors.
JCI insight, 3(19). https://doi.org/10.1172/jci.insight.99306
, Howlett J, Porter L, Truman L, Heywood J, Kennet J, Arbon EL, Anselmiova K, Walker NM, Atkar R, Pekalski ML, Rytina E, Evans M, Wicker LS, Todd JA, Mander AP, Bond S, & Waldron-Lynch F. (2018). The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes.
JCI insight, 3(19). https://doi.org/10.1172/jci.insight.99306
, Howlett J, Porter L, Truman L, Heywood J, Kennet J, Arbon EL, Anselmiova K, Walker NM, Atkar R, Pekalski ML, Rytina E, Evans M, Wicker LS, Todd JA, Mander AP, Bond S, & Waldron-Lynch F. (2018). The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes.
European Journal of Endocrinology, 176(3), 349–358. https://doi.org/10.1530/eje-16-0653
, Meyer, Stefanie, Timper, Katharina, Nigro, Nicole, Bally, Martina, Pernicova, Ida, Schuetz, Philipp, Müller, Beat, Korbonits, Marta, & Christ-Crain, Mirjam. (2017). Metformin prevents metabolic side effects during systemic glucocorticoid treatment.
European Journal of Endocrinology, 176(3), 349–358. https://doi.org/10.1530/eje-16-0653
, Meyer, Stefanie, Timper, Katharina, Nigro, Nicole, Bally, Martina, Pernicova, Ida, Schuetz, Philipp, Müller, Beat, Korbonits, Marta, & Christ-Crain, Mirjam. (2017). Metformin prevents metabolic side effects during systemic glucocorticoid treatment.
Cavelti-Weder, C., Timper, K., Molecular Therapy, 24(5), 1003–1012. https://doi.org/10.1038/mt.2015.227
, Keller, C., Osranek, M., Lassing, U., Spohn, G., Maurer, P., Muller, P., Jennings, G. T., Willers, J., Saudan, P., Donath, M. Y., & Bachmann, M. F. (2016). Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.
Cavelti-Weder, C., Timper, K., Molecular Therapy, 24(5), 1003–1012. https://doi.org/10.1038/mt.2015.227
, Keller, C., Osranek, M., Lassing, U., Spohn, G., Maurer, P., Muller, P., Jennings, G. T., Willers, J., Saudan, P., Donath, M. Y., & Bachmann, M. F. (2016). Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.
Diabetes & Metabolism, 42(6), 453–456. https://doi.org/10.1016/j.diabet.2016.08.005
, Timper, Katharina, Falconnier, Claudine, Stoeckli, Rolf, Bilz, Stefan, Oram, Richard A., McDonald, Timothy James, & Donath, Marc Y. (2016). Interleukin-1 antagonism in type 1 diabetes of long duration.
Diabetes & Metabolism, 42(6), 453–456. https://doi.org/10.1016/j.diabet.2016.08.005
, Timper, Katharina, Falconnier, Claudine, Stoeckli, Rolf, Bilz, Stefan, Oram, Richard A., McDonald, Timothy James, & Donath, Marc Y. (2016). Interleukin-1 antagonism in type 1 diabetes of long duration.
Nordmann, Thierry M., PLoS ONE, 10(10), e0139662. https://doi.org/10.1371/journal.pone.0139662
, Timper, Katharina, Cordes, Mareike, Coslovsky, Michael, Hanssen, Henner, Schmidt-Trucksäss, Arno, & Donath, Marc Y. (2015). Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.
Nordmann, Thierry M., PLoS ONE, 10(10), e0139662. https://doi.org/10.1371/journal.pone.0139662
, Timper, Katharina, Cordes, Mareike, Coslovsky, Michael, Hanssen, Henner, Schmidt-Trucksäss, Arno, & Donath, Marc Y. (2015). Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.
Timper, K., Journal of Diabetes and Its Complications, 29(7), 955–960. https://doi.org/10.1016/j.jdiacomp.2015.05.019
, Tsakiris, D. A., & Donath, M. Y. (2015). Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus.
Timper, K., Journal of Diabetes and Its Complications, 29(7), 955–960. https://doi.org/10.1016/j.jdiacomp.2015.05.019
, Tsakiris, D. A., & Donath, M. Y. (2015). Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus.
PLoS ONE, 8(8), e72876. https://doi.org/10.1371/journal.pone.0072876
, Bilz, Stefan, Keller, Ulrich, Meienberg, Fabian, & Christ-Crain, Mirjam. (2013). Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.
PLoS ONE, 8(8), e72876. https://doi.org/10.1371/journal.pone.0072876
, Bilz, Stefan, Keller, Ulrich, Meienberg, Fabian, & Christ-Crain, Mirjam. (2013). Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.
PLoS ONE, 8(4), e61780. https://doi.org/10.1371/journal.pone.0061780
, Keller, Ulrich, Klarhöfer, Markus, Scheffler, Klaus, Brand, Serge, Holsboer-Trachsler, Edith, Hatzinger, Martin, & Bilz, Stefan. (2013). Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study.
PLoS ONE, 8(4), e61780. https://doi.org/10.1371/journal.pone.0061780
, Keller, Ulrich, Klarhöfer, Markus, Scheffler, Klaus, Brand, Serge, Holsboer-Trachsler, Edith, Hatzinger, Martin, & Bilz, Stefan. (2013). Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study.